Blood clot prevention study after liver cancer surgery
Part of Blood & lymphatic, Digestive system, Heart & circulation clinical trials.
This trial tests whether a longer course of blood-thinning injections after major liver surgery reduces the risk of blood clots. It may help people recovering from liver cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having a major liver surgery (removing more than 2 sections of the liver) for cancer
- You are willing to receive daily injections after surgery to prevent blood clots
- You can understand and read English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This study tests a personalized approach to prevent blood clots in patients who have had surgery to repair blocked arteries in their legs. Researchers want to find the best blood-thinning medication for each individual to reduce serious complications while keeping you safe.
This study compares two approaches to preventing blood clots around the time of liver surgery. If you’re having planned liver surgery, it may help doctors choose the safest timing and method for clot prevention.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
This trial tests a blood-thinning drug to prevent dangerous blood clots (venous thromboembolism) in people with colorectal cancer who are having surgery. It aims to see if the drug can help reduce clot risk safely.
Hear when a new Surgery-Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.